Companies / Prelude Therapeutics Incorporated / Activity
Activity — Prelude Therapeutics Incorporated
28 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $8.16M | +1.5M +575.04% | 1,797,501 2.25% of shares | medium |
| Q2 2025 as of | Boxer Capital Management, LLC 13F manager | Exit | Common stock | $-1.62M | -2.1M -100.00% | 0 | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $1.61M | +301K +236.85% | 428,787 0.54% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common stock | $792.6K | +232K +153.47% | 382,737 0.48% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | Exit | Common stock | $-465.9K | -161K -100.00% | 0 | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $461.5K | +135K +17.11% | 923,626 1.16% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-458.9K | -81K -88.64% | 10,322 0.01% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | Common stock | $290.8K | +85K +31.04% | 358,906 0.45% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $148.3K | +28K | 27,824 0.03% of shares | low |
| Q1 2026 as of | OMERS Administration Corporation 13F manager | Trim | Common stock | $-137.8K | -40K -55.21% | 32,700 0.04% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $101.2K | +30K +10.84% | 302,458 0.38% of shares | low |
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $73.5K | +17K +129.24% | 30,526 0.04% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-48.1K | -10K -33.21% | 20,387 0.03% of shares | low |
| Q1 2026 as of | Graham Capital Management, L.P. 13F manager | New | Common stock | $38.8K | +11K | 11,343 0.01% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $26.0K | +13K +86.05% | 27,165 0.03% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Add | Common stock | $22.4K | +7K +120.03% | 13,316 0.02% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-22.0K | -6K -28.38% | 14,601 0.02% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-19.2K | -4K -41.37% | 6,052 <0.01% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $13.3K | +4K +1.44% | 275,200 0.34% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-11.8K | -15K -62.83% | 8,602 0.01% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | Add | Common stock | $6.5K | +2K +12.24% | 17,420 0.02% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-5.1K | -7K -22.26% | 23,145 0.03% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Add | Common stock | $3.3K | +3K +9.60% | 29,773 0.04% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $2.8K | +960 +10.85% | 9,808 0.01% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Add | Common stock | $2.0K | +589 +33.81% | 2,331 <0.01% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-319 | -110 -1.26% | 8,602 0.01% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Add | Common stock | $158 | +110 +1.28% | 8,712 0.01% of shares | low |
| Q4 2025 as of | IFP Advisors, Inc 13F manager | Trim | Common stock | $-51 | -17 -94.44% | 1 <0.01% of shares | low |